单视图与标准多视图评估整体纵向应变在癌症治疗中心脏毒性诊断中的比较。
Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy.
机构信息
Toronto General Hospital, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, University of Toronto, Toronto, Canada.
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
出版信息
JACC Cardiovasc Imaging. 2018 Aug;11(8):1109-1118. doi: 10.1016/j.jcmg.2018.03.003. Epub 2018 May 16.
OBJECTIVES
The goal of this study was to compare echocardiographic measurements of global longitudinal strain (GLS) (using 3 apical views) with single-view longitudinal strain (LS, 4- or 2-chamber [4CV_LS and 2CV_LS, respectively]) for detection of cancer-therapy related cardiotoxicity.
BACKGROUND
GLS is useful for the detection of cardiotoxicity, but the need for repeated measurements poses a significant burden on busy echocardiography laboratories. A single-view LS measurement, possibly at point of care, could improve efficiency.
METHODS
Seventeen international centers prospectively recruited 108 patients (mean age 54 ± 13 years) at high risk for cardiotoxicity as part of the ongoing SUCCOUR (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy) randomized controlled trial. Echocardiography performed at baseline and follow-up were analyzed in a core laboratory setting blinded to clinical information. Peak systolic GLS and LS were measured from raw data. Cardiotoxicity was defined by reduction in left ventricular ejection fraction >0.10 to <0.55 or a relative drop in GLS by ≥12%.
RESULTS
Cardiotoxicity developed in 46 patients by either criteria. Baseline and follow-up 2-dimensional left ventricular ejection fraction were 61 ± 4% and 58 ± 5%, respectively (p < 0.001). The baseline GLS (-20.9 ± 2.4%) was not different from 4CV_LS (-20.7 ± 2.5%; p = 0.09) or 2CV_LS (-21.1 ± 3.1%; p = 0.25). The follow-up GLS (-19.5 ± 2.4%) was also similar to 4CV_LS (-19.5 ± 2.6%; p = 0.80) and 2CV_LS (-19.7 ± 3.1%; p = 0.19). There was good correlation between GLS and 4CV_LS at baseline (r = 0.86; p < 0.001) and follow-up (r = 0.89; p < 0.001) and with 2CV_LS at baseline (r = 0.87; p < 0.001) and follow-up (r = 0.88; p < 0.001). However, there was 15% to 22% disagreement between GLS and 4CV_LS or 2CV_LS for the detection of cardiotoxicity. The interobserver and intraobserver reproducibility was higher for GLS (intraclass correlation: 0.93 to 0.95; coefficient of variance: 2.9% to 3.7%) compared with either single-chamber-based LS measurement (intraclass correlation: 0.85 to 0.91; coefficient of variance: 4.1% to 4.8%).
CONCLUSIONS
Although there was good correlation between GLS and single-view LS measurements, single-view LS measurement led to disagreement in the diagnosis of cardiotoxicity in up to 22% of patients. GLS measurements were more reproducible than single-view LS. GLS based on 3 apical views should remain the preferred technique for detection of cardiotoxicity. (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy [SUCCOUR]; ACTRN12614000341628).
目的
本研究旨在比较整体纵向应变(GLS)的超声心动图测量值(使用 3 个心尖切面)与单切面纵向应变(LS,分别为 4 腔心[4CV_LS]和 2 腔心[2CV_LS])在检测癌症治疗相关性心脏毒性方面的差异。
背景
GLS 对心脏毒性的检测很有用,但重复测量的需求给繁忙的超声心动图实验室带来了很大的负担。单点 LS 测量,可能在床边进行,可能会提高效率。
方法
作为正在进行的 SUCCOUR(化疗期间监测应变以改善心血管结局)随机对照试验的一部分,17 个国际中心前瞻性招募了 108 例高危心脏毒性的患者(平均年龄 54 ± 13 岁)。在核心实验室设置中对基线和随访时的超声心动图进行分析,结果对临床信息进行了盲法评估。从原始数据中测量峰值收缩期 GLS 和 LS。通过左心室射血分数降低>0.10 至<0.55 或 GLS 相对下降≥12%来定义心脏毒性。
结果
按照任一标准,46 例患者发生了心脏毒性。基线和随访的二维左心室射血分数分别为 61 ± 4%和 58 ± 5%(p<0.001)。基线 GLS(-20.9 ± 2.4%)与 4CV_LS(-20.7 ± 2.5%;p=0.09)或 2CV_LS(-21.1 ± 3.1%;p=0.25)无差异。随访 GLS(-19.5 ± 2.4%)与 4CV_LS(-19.5 ± 2.6%;p=0.80)和 2CV_LS(-19.7 ± 3.1%;p=0.19)也相似。GLS 与 4CV_LS 在基线(r=0.86;p<0.001)和随访(r=0.89;p<0.001)以及与 2CV_LS 在基线(r=0.87;p<0.001)和随访(r=0.88;p<0.001)均具有良好的相关性。然而,GLS 与 4CV_LS 或 2CV_LS 在检测心脏毒性方面存在 15%至 22%的差异。与单点 LS 测量相比,GLS 的观察者内和观察者间可重复性更高(组内相关系数:0.93 至 0.95;变异系数:2.9% 至 3.7%)(组内相关系数:0.85 至 0.91;变异系数:4.1% 至 4.8%)。
结论
尽管 GLS 与单点 LS 测量值之间具有良好的相关性,但单点 LS 测量在多达 22%的患者中导致心脏毒性的诊断存在差异。GLS 测量比单点 LS 更具可重复性。基于 3 个心尖切面的 GLS 应继续作为检测心脏毒性的首选技术。(化疗期间监测应变以改善心血管结局研究[SUCCOUR];ACTRN12614000341628)。